Urological Devices – Market Insights – Europe

Driven by the increasing prevalence of kidney diseases, aging population, product innovation, and patient awareness of urological treatments in this region, the European urological device market will continue to expand through 2033. Furthermore, favorable demographic trends, an increasing prevalence of obesity, adoption of premium devices, and the growing availability of less invasive treatment options will support urological procedure volume growth. Moreover, the rising use of minimally invasive laser treatments that have reduced postoperative pain and shorter recovery periods in Europe, will result in increased adoption of associated devices.

This Medtech 360 Report provides comprehensive data and analysis on the of the market for urological devices in Europe from 2019 through 2033.

Emerging technologies and innovative products will grow in popularity at the expense of competing treatment options.

What are the most recent technological innovations in the urological device market?

How will these innovations affect the efficacy and utilization of procedures in these segments?

How will the growing preference for ureteroscopy affect the stone management device market?

What role does strong clinical evidence play in the adoption of new technologies and devices?

Mergers and acquisitions have been altering the competitive landscape.

What are the most relevant recent acquisitions affecting the market?

How will market shares and product portfolios be affected as a result of these acquisitions?

Minimally invasive treatment volumes will increase in Europe over the forecast period.

What factors contribute to the increase of minimally invasive treatments?

How have minimally invasive treatment options changed the BPH device market?

Which market segments will see the greatest adoption of minimally invasive treatments?

What is the impact of Aquablation on the Europe urological device market?

UI device segment represents a significant proportion of the overall market revenues.

What factors impact the use of UI devices?

How will the change in ASPs of UI devices affect the market?

Premium devices and their adoption will influence market trends.

Which markets are going to be affected by preference for premium variants of devices?

The negative publicity surrounding the safety of synthetic mesh products will impact the market.

How will this impact the genitourinary mesh market in Europe?

How are physicians in the European market reacting compared to those in the US?